Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display.

Kunamneni A, Clarke EC, Ye C, Bradfute SB, Durvasula R.

Am J Trop Med Hyg. 2019 May 6. doi: 10.4269/ajtmh.18-0658. [Epub ahead of print]

PMID:
31074409
2.

Ribosome display for the rapid generation of high-affinity Zika-neutralizing single-chain antibodies.

Kunamneni A, Ye C, Bradfute SB, Durvasula R.

PLoS One. 2018 Nov 16;13(11):e0205743. doi: 10.1371/journal.pone.0205743. eCollection 2018.

3.

Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.

Hraber P, Bradfute S, Clarke E, Ye C, Pitard B.

Vaccine. 2018 Nov 12;36(46):6911-6917. doi: 10.1016/j.vaccine.2018.10.022. Epub 2018 Oct 15.

PMID:
30337177
4.

Ebola virus vaccination and the longevity of total versus neutralising antibody response-is it enough?

Bornholdt ZA, Bradfute SB.

Lancet Infect Dis. 2018 Jul;18(7):699-700. doi: 10.1016/S1473-3099(18)30175-0. Epub 2018 Apr 5. No abstract available.

PMID:
29627146
5.

Production and Purification of Filovirus Glycoproteins in Insect and Mammalian Cell Lines.

Clarke EC, Collar AL, Ye C, Caì Y, Anaya E, Rinaldi D, Martinez B, Yarborough S, Merle C, Theisen M, Wada J, Kuhn JH, Bradfute SB.

Sci Rep. 2017 Nov 8;7(1):15091. doi: 10.1038/s41598-017-15416-3.

6.

Advances in Ebola virus vaccination.

Clarke EC, Bradfute SB.

Lancet Infect Dis. 2017 Aug;17(8):787-788. doi: 10.1016/S1473-3099(17)30320-1. Epub 2017 Jun 9. No abstract available.

PMID:
28606592
7.

Comparison of N- and O-linked glycosylation patterns of ebolavirus glycoproteins.

Collar AL, Clarke EC, Anaya E, Merrill D, Yarborough S, Anthony SM, Kuhn JH, Merle C, Theisen M, Bradfute SB.

Virology. 2017 Feb;502:39-47. doi: 10.1016/j.virol.2016.12.010. Epub 2016 Dec 13.

8.

The early clinical development of Ebola virus treatments.

Bradfute SB.

Expert Opin Investig Drugs. 2017 Jan;26(1):1-4. doi: 10.1080/13543784.2017.1260545. Epub 2016 Nov 21. No abstract available.

PMID:
27838928
9.

Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.

Konduru K, Shurtleff AC, Bradfute SB, Nakamura S, Bavari S, Kaplan G.

PLoS One. 2016 Sep 13;11(9):e0162446. doi: 10.1371/journal.pone.0162446. eCollection 2016.

10.

Duration of immune responses after Ebola virus vaccination.

Bradfute SB.

Lancet Infect Dis. 2016 Jan;16(1):2-3. doi: 10.1016/S1473-3099(15)00408-9. Epub 2015 Nov 4. No abstract available.

11.

Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential.

Chauhan S, Ahmed Z, Bradfute SB, Arko-Mensah J, Mandell MA, Won Choi S, Kimura T, Blanchet F, Waller A, Mudd MH, Jiang S, Sklar L, Timmins GS, Maphis N, Bhaskar K, Piguet V, Deretic V.

Nat Commun. 2015 Oct 27;6:8620. doi: 10.1038/ncomms9620.

12.

Filoviruses: One of These Things is (not) Like the Other.

Anthony SM, Bradfute SB.

Viruses. 2015 Sep 29;7(10):5172-90. doi: 10.3390/v7102867. Review.

13.

Eastern equine encephalitis virus in mice I: clinical course and outcome are dependent on route of exposure.

Honnold SP, Mossel EC, Bakken RR, Fisher D, Lind CM, Cohen JW, Eccleston LT, Spurgers KB, Erwin-Cohen R, Bradfute SB, Maheshwari RK, Glass PJ.

Virol J. 2015 Sep 29;12:152. doi: 10.1186/s12985-015-0386-1.

14.

Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.

Bradfute SB, Anthony SM, Stuthman KS, Ayithan N, Tailor P, Shaia CI, Bray M, Ozato K, Bavari S.

PLoS One. 2015 Mar 18;10(3):e0118434. doi: 10.1371/journal.pone.0118434. eCollection 2015.

15.

Staphylococcus aureus: Current State of Prevalence, Impact, and Vaccine Development.

Brett M, Bradfute SB.

Curr Pharm Des. 2015;21(16):2131-5. Review.

PMID:
25760341
16.

Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection.

Ayithan N, Bradfute SB, Anthony SM, Stuthman KS, Bavari S, Bray M, Ozato K.

PLoS One. 2015 Feb 26;10(2):e0118345. doi: 10.1371/journal.pone.0118345. eCollection 2015.

17.

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, Doggett NA, Dolnik O, Dye JM, Enterlein S, Fenimore PW, Formenty P, Freiberg AN, Garry RF, Garza NL, Gire SK, Gonzalez JP, Griffiths A, Happi CT, Hensley LE, Herbert AS, Hevey MC, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson JC, Johnson KM, Kindrachuk J, Klenk HD, Kobinger G, Kochel TJ, Lackemeyer MG, Lackner DF, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Omilabu SA, Palacios G, Panchal RG, Park DJ, Patterson JL, Paweska JT, Peters CJ, Pettitt J, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Sabeti PC, Sealfon R, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Viruses. 2014 Sep 26;6(9):3663-82. doi: 10.3390/v6093663.

18.

Induced IL-10 splice altering approach to antiviral drug discovery.

Panchal RG, Mourich DV, Bradfute S, Hauck LL, Warfield KL, Iversen PL, Bavari S.

Nucleic Acid Ther. 2014 Jun;24(3):179-85. doi: 10.1089/nat.2013.0457. Epub 2014 Mar 21.

PMID:
24655055
19.

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.

Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Arch Virol. 2014 May;159(5):1229-37. doi: 10.1007/s00705-013-1877-2. Epub 2013 Nov 5.

20.

Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.

Ayithan N, Bradfute SB, Anthony SM, Stuthman KS, Dye JM, Bavari S, Bray M, Ozato K.

J Interferon Cytokine Res. 2014 Feb;34(2):79-89. doi: 10.1089/jir.2013.0035. Epub 2013 Oct 8.

Supplemental Content

Loading ...
Support Center